Gerresheimer AG

GXI

DE000A0LD6E6

Medical Equipment, Supplies & Distribution

Market Closed - Xetra Other stock markets 11:35:23 2024-09-17 am EDT			5-day change	1st Jan Change
103.20 ^EUR	+3.46%		-1.99%	+9.38%

Sep. 17	GERRESHEIMER AG : Jefferies keeps its Buy rating	ZD
Sep. 16	GERRESHEIMER AG : Buy rating from Deutsche Bank	ZD

GERRESHEIMER AG : Gets a Buy rating from Deutsche Bank

July 16, 2024 at 06:49 am EDT

In a research note, Deutsche Bank analyst Falko Friedrichs has maintained his recommendation on the stock with a Buy rating. The target price is unchanged at EUR 130.

Latest news about Gerresheimer AG

GERRESHEIMER AG : Jefferies keeps its Buy rating	Sep. 17	ZD
GERRESHEIMER AG : Buy rating from Deutsche Bank	Sep. 16	ZD
GERRESHEIMER AG : Berenberg remains its Buy rating	Sep. 11	ZD
GERRESHEIMER AG : Jefferies gives a Buy rating	Sep. 11	ZD
Schott Pharma shares rise significantly - more optimistic outlook	Aug. 29	DP
GERRESHEIMER AG : JP Morgan reaffirms its Buy rating	Aug. 29	ZD
Aktien Frankfurt Eroffnung: Dax remains stable despite Nvida disappointment	Aug. 29	DP
GERRESHEIMER AG : Jefferies reiterates its Buy rating	Aug. 15	ZD
GERRESHEIMER AG : Gets a Buy rating from DZ Bank	Aug. 06	ZD
M. M. Warburg & Co. Begins Gerresheimer Coverage at Buy	Aug. 02	MT
GERRESHEIMER AG : From Neutral to Buy by Warburg Research	Aug. 02	ZD
GERRESHEIMER AG : JP Morgan maintains a Buy rating	Jul. 25	ZD
GERRESHEIMER AG : UBS reiterates its Buy rating	Jul. 17	ZD
GERRESHEIMER AG : Gets a Buy rating from Deutsche Bank	Jul. 16	ZD
GERRESHEIMER AG : Berenberg remains its Buy rating	Jul. 15	ZD
GERRESHEIMER AG : Deutsche Bank reaffirms its Buy rating	Jul. 12	ZD
GERRESHEIMER AG : Receives a Buy rating from Hauck & Aufhauser	Jul. 12	ZD
JPMorgan lowers Gerresheimer target to 121.80 euros - 'Overweight'	Jul. 12	DP
GERRESHEIMER AG : JP Morgan gives a Buy rating	Jul. 12	ZD
Gerresheimer remains on growth track	Jul. 11	RE
Gerresheimer fluctuates strongly after quarterly figures	Jul. 11	DP
Transcript : Gerresheimer AG, Q2 2024 Earnings Call, Jul 11, 2024	Jul. 11
JPMorgan leaves Gerresheimer at 'Overweight' - figures 'good enough'	Jul. 11	DP
Gerresheimer counts on recovery in the second half of the year - shares in demand	Jul. 11	DP
GERRESHEIMER AG : Buy rating from Jefferies	Jul. 11	ZD

Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.

Employees

11,913

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-09-24 - Medtec China Conference

More about the company